Abstracts tagged "Disease Activity and patient engagement"

Abstract Number: 408 • 2016 ACR/ARHP Annual Meeting
Development and Initial Validation of the Parent and Child Versions of the Juvenile Arthritis Disease Activity Score
Alessandro Consolaro^1,2, Pieter van Dijkhuizen³, Giedre Januskeviciute³, Valentina Muratore⁴, Gabriella Giancane⁵, Alberto Martini^1,2 and Angelo Ravelli^1,2, ¹Istituto Giannina Gaslini, Genoa, Italy, ²University of Genova, Genova, Italy, ³Istituto Giannina Gaslini, Genova, Italy, ⁴Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, ⁵Pediatria II, Reumatologia, PRINTO, Istituto Giannina Gaslini, Genoa, Italy
Background/Purpose: Incorporation of parent-/child-reported outcomes in patient assessment is deemed increasingly important in the managment of children with juvenile idiopathic arthritis (JIA). Aim of the…
Abstract Number: 1161 • 2016 ACR/ARHP Annual Meeting
Systematic Development of a Patient-Centered Strategy to Improve Tight Control in Daily Clinical Practice
Marieke J. de Jonge¹, Sofie H.M. Manders¹, Anita M.P. Huis¹, Mart A.F.J. van de Laar², Piet L.C.M. van Riel^1,3 and Marlies E.J.L. Hulscher¹, ¹Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, ²University of Twente, Department of Psychology, Health and Technology, Enschede, Netherlands, ³Bernhoven, Department of Rheumatology, Uden, Netherlands
Background/Purpose: Patients are not aware of the important role of disease activity in Rheumatoid Arthritis (RA) for long term clinical outcomes. This not only prevents…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].